Featured Articles and Interviews
Aug 28, 2025
How to Invest in Gene Stocks and ETFs
More Featured Articles and Inverviews
Press Releases
More Press Releases
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.